There are 168 hours in a week, of which 100 is routinely spent by me on GeneYes. I give my heart and soul to our mission to improve genetic testing decision support. I love it! I am trying to do everything possible to make it a widely available, clinically useful, lifesaving product that makes money. My time is split between team building, software development oversight, clinical oversight, and business development.
After having personally experienced the problem that GeneYes plans to solve, I initially spent considerable time researching the nature of the problem, the extent of the problem, the degree of pain the problem causes, who suffers directly and indirectly from the problem, and what cost-effective and customer-focused solution could truly solve the problem.
One of the most significant challenges GeneYes faces, as do all physicians, is the constant emergence of new clinical studies adding to the body of genetic testing knowledge. At the moment, I spend considerable time trying to stay current with the emerging knowledge necessary to keep our product-market fit superior and essential, both clinically and competitively. This requires constant interaction with experts, potential customers, and potential partners in the field worldwide, as well as reading studies and media outputs. This effort has paid dividends as it has helped me identify the best and most reliable sources of knowledge.
In addition, I continue to focus on the talent acquisition needed to scale the company by identifying individuals with relevant skills, or people who may know such people, and engaging them in discussions. Through this extensive, time-consuming, but ridiculously important process, I have been successful in recruiting high caliber people to the team so far.
I also spend time on positioning the company for fundraising by honing our message. However, not much time has been spent yet on public messaging as I am waiting to have in hand the results of our Harvard pending study, which I expect will generate significant buzz over its accomplishment of effective and accurate simulated medical interviewing. My time is also focused on trying to identify potential advisors with academia and the market. I have many conversations and follow many leads, but have been highly selective to date. The bottom line for me is balancing the immediate development needs of GeneYes with an eye and planning towards the longer term needs of market positioning, entry and penetration. more